Want to use our logo?

Download the ICS Branding Pack

ICS Background

Mary Gardner

View User Details

Mary Gardner


You must be logged in to view this contact
to ICS

Mary Gardner, CEO and Founder of DelNova Inc., and former Director of Technology Assessment, Hospira, a Pfizer company (~11 yrs), has dedicated her career in the area of innovation and commercialization for the pharma/biotech & life science industry. DelNova (founded in 2016) is focused on applying drug delivery expertise for superior therapeutic benefit. Mary is the inventor, of a novel product candidate, ReVivox™ now under development.
At Hospira/Pfizer, Mary was responsible for the front end of innovation, including supporting business development via the sourcing & evaluation of external new technology and product opportunities to generate future topline growth in healthcare products (pharmaceuticals, drug delivery and medical devices). Is experienced in the healthcare & biotechnology industries including positions in consulting, process design engineering and project management. Prior to joining Hospira, Mary led the Business Development office of The Lawson Health Research Institute & London Health Sciences Centre, London Ontario. Here she was responsible for managing the IP portfolio, technology transfer & spin-off companies created from innovations arising out of leading Canadian teaching hospitals. Education; MBA (finance& innovation) from McMaster University, Hamilton and a BEngSc (Chemical & Biochemical) from the University of Western Ontario, London, Canada and is a Certified Licensing Professional (CLP).